Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

New treatments for male hypogonadism are effective and should be personalized.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.